caffeine has been researched along with ADPKD in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Caffeine has been proposed, based on in vitro cultured cell studies, to accelerate progression of autosomal dominant polycystic kidney disease (ADPKD) by increasing kidney size." | 3.88 | Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. ( Bae, KT; Bennett, WM; Chapman, AB; El Ters, M; Harris, PC; Landsittel, DP; Mahnken, JD; McKenzie, KA; Mrug, M; Rahbari-Oskoui, FF; Torres, VE; Yu, ASL, 2018) |
| "Because caffeine may induce cyst and kidney enlargement in autosomal dominant polycystic kidney disease (ADPKD), we evaluated caffeine intake and renal volume using renal ultrasound in ADPKD patients." | 3.78 | Caffeine intake by patients with autosomal dominant polycystic kidney disease. ( Baxmann, AC; Heilberg, IP; Nishiura, JL; Vendramini, LC, 2012) |
| "Mural epithelial cells from ADPKD cysts and normal human kidney cortex cells (HKC) were cultured, and cAMP levels were determined in response to caffeine and receptor-mediated agonists linked to adenylyl cyclase." | 1.31 | The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. ( Belibi, FA; Christensen, M; Grantham, JJ; Reif, G; Wallace, DP; Yamaguchi, T, 2002) |
| "Volumes of total liver, hepatic cysts, hepatic parenchyma, and total kidney were measured by a validated computed tomography (CT) technique." | 1.30 | Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. ( Bronner, T; Everson, GT; McKinley, C; Russ, P; Scherzinger, A; Sherstha, R; Showalter, R, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McKenzie, KA | 1 |
| El Ters, M | 1 |
| Torres, VE | 1 |
| Harris, PC | 1 |
| Chapman, AB | 1 |
| Mrug, M | 1 |
| Rahbari-Oskoui, FF | 1 |
| Bae, KT | 1 |
| Landsittel, DP | 1 |
| Bennett, WM | 1 |
| Yu, ASL | 1 |
| Mahnken, JD | 1 |
| Campbell, KL | 1 |
| Rangan, GK | 1 |
| Lopez-Vargas, P | 1 |
| Tong, A | 1 |
| Vendramini, LC | 1 |
| Nishiura, JL | 1 |
| Baxmann, AC | 1 |
| Heilberg, IP | 1 |
| Belibi, FA | 1 |
| Wallace, DP | 1 |
| Yamaguchi, T | 1 |
| Christensen, M | 1 |
| Reif, G | 1 |
| Grantham, JJ | 1 |
| Nauli, SM | 1 |
| Alenghat, FJ | 1 |
| Luo, Y | 1 |
| Williams, E | 1 |
| Vassilev, P | 1 |
| Li, X | 1 |
| Elia, AE | 1 |
| Lu, W | 1 |
| Brown, EM | 1 |
| Quinn, SJ | 1 |
| Ingber, DE | 1 |
| Zhou, J | 1 |
| Sherstha, R | 1 |
| McKinley, C | 1 |
| Russ, P | 1 |
| Scherzinger, A | 1 |
| Bronner, T | 1 |
| Showalter, R | 1 |
| Everson, GT | 1 |
1 review available for caffeine and ADPKD
| Article | Year |
|---|---|
KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Diet and Lifestyle Management.
Topics: Blood Pressure; Blood Pressure Monitoring, Ambulatory; Caffeine; Diet; Dietary Proteins; Disease Pro | 2015 |
5 other studies available for caffeine and ADPKD
| Article | Year |
|---|---|
Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.
Topics: Adult; Caffeine; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estim | 2018 |
Caffeine intake by patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Analysis of Variance; Body Mass Index; Caffeine; Case-Control Studies; Cross-Sectional Studie | 2012 |
The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease.
Topics: Caffeine; Cells, Cultured; Cyclic AMP; Deamino Arginine Vasopressin; Dinoprostone; Electrophysiology | 2002 |
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells.
Topics: Animals; Caffeine; Calcium; Calcium Channels; Cilia; Epithelium; GTP-Binding Proteins; Heterozygote; | 2003 |
Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease.
Topics: Antipyrine; Caffeine; Cysts; Estrogen Replacement Therapy; Female; Hormones; Humans; Kidney; Liver; | 1997 |